Adient plc (ADNT)
| Market Cap | 1.42B -27.3% |
| Revenue (ttm) | 15.13B +5.0% |
| Net Income | 48.00M |
| EPS | 0.60 |
| Shares Out | 77.10M |
| PE Ratio | 30.80 |
| Forward PE | 7.65 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 824,221 |
| Open | 19.30 |
| Previous Close | 18.76 |
| Day's Range | 18.23 - 19.34 |
| 52-Week Range | 17.68 - 27.32 |
| Beta | 1.53 |
| Analysts | Buy |
| Price Target | 29.55 (+60.86%) |
| Earnings Date | Nov 4, 2026 |
About ADNT
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks in United States. Its automotive seating solutions include complete seating systems, mechanisms, frames, foams, head restraints, armrests, and trim covers. The company serves automotive original equipment manufacturers in North America and South America; Europe, Middle East, and Africa; and Asia. Adient plc was incorporated in 2016 and is based in Dublin, Ireland.
Financial Performance
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for ADNT stock is "Buy." The 12-month stock price target is $29.55, which is an increase of 60.86% from the latest price.
News
Adient upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Adient (ADNT) to Overweight from Neutral with a price target of $25, down from $28. The firm says automation, footprint optimization and lower restructuring costs offer a “meaningful...
Adient price target lowered to $21 from $22 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Adient (ADNT) to $21 from $22 and keeps an Equal Weight rating on the shares.
Adient's Ana Romero-Davila is recognized as a Rising Star
PLYMOUTH, Mich., Aug. 17, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced that Ana Romero-Davila, platform director at the company, has been named a 20...
Adient Transcript: J.P. Morgan Automotive Conference
Strong execution in 2026 is driving optimism for 2027, with growth in Americas and China, margin expansion from automation and restructuring, and balanced capital allocation. Americas leads with new business wins and innovation, while Europe and China focus on margin management and efficiency gains.
Adient Slides: J.P. Morgan Automotive Conference
Adient has posted slides in relation to its latest quarterly earnings report, which was published on August 13, 2026.
Adient price target lowered to $29 from $33 at Citi
Citi analyst Michael Ward lowered the firm’s price target on Adient (ADNT) to $29 from $33 and keeps a Buy rating on the shares.
Adient price target raised to $28 from $26 at JPMorgan
JPMorgan raised the firm’s price target on Adient (ADNT) to $28 from $26 and keeps a Neutral rating on the shares.
Adient price target lowered to $25 from $29 at Barclays
Barclays analyst Dan Levy lowered the firm’s price target on Adient (ADNT) to $25 from $29 and keeps an Equal Weight rating on the shares.
Adient price target lowered to $28 from $29 at Deutsche Bank
Deutsche Bank analyst Edison Yu lowered the firm’s price target on Adient (ADNT) to $28 from $29 and keeps a Buy rating on the shares.
Adient price target lowered to $29 from $34 at UBS
UBS lowered the firm’s price target on Adient (ADNT) to $29 from $34 and keeps a Buy rating on the shares.
Adient Earnings Call Transcript: Q3 2026
Q3 revenue rose 5% year-over-year to $3.9 billion, with adjusted EBITDA flat at $225 million due to external cost pressures. Americas and Asia drove growth, while EMEA improved through restructuring. Fiscal 2026 revenue guidance was raised to ~$15 billion, with solid liquidity and continued focus on automation and capital discipline.
Adient Slides: Q3 2026
Adient has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on August 5, 2026.
Adient Earnings release: Q3 2026
Adient released its Q3 2026 earnings on August 5, 2026, summarizing the period's financial results.
Adient Quarterly report: Q3 2026
Adient has published its Q3 2026 quarterly earnings report on August 5, 2026.
Adient raises FY26 revenue view to $15B from $14.8B, consensus $14.85B
Backs FY26 adjusted EBITDA view $885M. Backs FY26 capital expenditures view $300M.
Adient reports Q3 adjusted EPS 48c, consensus 57c
Reports Q3 revenue $3.93B, consensus $3.72B. The company said, “The combination of engineering leadership, commercial discipline and operational execution continues to differentiate Adient (ADNT), ena...
Adient reports third quarter financial results; reaffirms earnings and FCF outlook for FY26
PLYMOUTH, Mich., Aug. 5, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced its third quarter 2026 financial results.
Adient upgraded to Outperform from Neutral at BNP Paribas
BNP Paribas analyst James Picariello upgraded Adient (ADNT) to Outperform from Neutral with a $26 price target
Adient price target lowered to $26 from $28 at Stifel
Stifel lowered the firm’s price target on Adient (ADNT) to $26 from $28 and keeps a Buy rating on the shares. In a Q2 preview for the firm’s diversified industrials…
Adient to discuss Q3 fiscal 2026 financial results on August 5, 2026
PLYMOUTH, Mich., July 14, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, will host a conference call on August 5, 2026, at 8:30 a.m.
Adient price target raised to $34 from $33 at UBS
UBS analyst Joseph Spak raised the firm’s price target on Adient (ADNT) to $34 from $33 and keeps a Buy rating on the shares.
Adient price target lowered to $29 from $31 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Adient (ADNT) to $29 from $31 and keeps a Buy rating on the shares ahead of fiscal Q3 earnings. Published first on…
Adient price target raised to $29 from $26 at Barclays
Barclays raised the firm’s price target on Adient (ADNT) to $29 from $26 and keeps an Equal Weight rating on the shares.
Adient price target raised to $28 from $26 at Stifel
Stifel analyst Nathan Jones raised the firm’s price target on Adient (ADNT) to $28 from $26 and keeps a Buy rating on the shares.
Adient price target raised to $33 from $32 at UBS
UBS raised the firm’s price target on Adient (ADNT) to $33 from $32 and keeps a Buy rating on the shares.